Last reviewed · How we verify

NCT07067944

Prophylactic Perioperative Infusion of Ephedrine Versus Noradrenaline in Patients Undergoing Cesarean Delivery Under Spinal Anesthesia

Completed NA Last updated 16 July 2025
What this trial tests

NA trial testing Ephedrine in Perioperative Infusion in 100 participants. Completed in 1 March 2024.

Timeline
1 July 2023
Primary endpoint
1 March 2024
1 March 2024

Quick facts

Lead sponsorTanta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment100
Start date1 July 2023
Primary completion1 March 2024
Estimated completion1 March 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

21 and older, female only, with Perioperative Infusion or Ephedrine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare the effects of prophylactic ephedrine and nor-epinephrine infusion on maternal hemodynamics and neonatal outcomes following spinal anesthesia in cesarean deliveries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ephedrine

Trials testing the same drug.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07067944.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing